When Isobel* first heard the rumours that there may be more to Kim Kardashian's recent weight loss than a dedicated healthy eating and workout routine she ...
[disordered eating](https://www.womenshealthmag.com/uk/food/a42061764/zara-mcdermott-disordered-eating-documentary/). According to the [NHS](https://urldefense.com/v3/__https://www.nhs.uk/common-health-questions/food-and-diet/what-should-my-daily-intake-of-calories-be/*:*:text=An*20ideal*20daily*20intake*20of,women*20and*202*2C500*20for*20men.__;I34lJSUlJSUlJSU!!Ivohdkk!gweDgUa_v_kbtObKJFPLEC1t3DxYsWddwFs1dbjM-18eYx-_AEItFc8khh63WfW_C_3r1nnWAX5UCzOe2v30tdkC6IjQ8qVRC299v2vKrAY%24), the recommended daily calorie intake for women is 2,000, and the recommended pace for healthy weight loss being just two pounds per week. They offer a shortcut to managing weight - instead of learning healthier ways of managing weight and appetite - which can be dangerous, especially for those who are vulnerable to having difficulties with body image and eating.’ Their relationship with food is likely to already be an unhealthy one which is why they are choosing to take the medication in the first place. ‘I tell all my patients that if after six months you have not changed the way you eat or your activity, you are going to gain weight back,’ explains [Dr Joseph Arulandu](https://urldefense.com/v3/__https://www.nwmedicalgroup.com/doctors-providers/arulandu-joseph-md-facp-4997?utm_campaign=gmb&utm_medium=organic&utm_source=local__;!!Ivohdkk!gweDgUa_v_kbtObKJFPLEC1t3DxYsWddwFs1dbjM-18eYx-_AEItFc8khh63WfW_C_3r1nnWAX5UCzOe2v30tdkC6IjQ8qVRC299VefQf_M%24), who is qualified in internal and obesity medicine. [diabetes](https://www.womenshealthmag.com/uk/health/a33083277/type-2-diabetes-diet/), where prescriptions will remain free for those with the condition. ‘It’s even more worrying if those drugs are being used for purposes that they are not intended to be used for.’ One of the problems is that, on some sites, it’s not possible to verify the quality of ‘weight loss injections’ offered at the click of a button. It is prescribed in various doses and can be in the form of a weekly injection - administered in the stomach, thigh or arm - or a daily oral tablet. [Khloe](https://www.womenshealthmag.com/uk/beauty/hair/a42283613/khloe-kardashian-blunt-bangs-fringe-haircut/), have taken the medication mainstream. Indeed, while Ozempic and Rybelsus are currently approved this side of the pond to treat type 2 diabetes, Wegovy has only just been given the go ahead for obesity by The National Institute for Health and Care Excellence (NICE). This spike in attention is filling the pockets of the medications’ Danish manufacturer Novo Nordisk, who pocketed $3.4bn in 2020 alone, and are projected to make $7.8bn by 2023 - particularly as use of Ozempic in the UK soars. A much-discussed [Variety](https://urldefense.com/v3/__https://variety.com/2022/film/actors/weight-loss-ozempic-semaglutide-hollywood-1235361465/__;!!Ivohdkk!gweDgUa_v_kbtObKJFPLEC1t3DxYsWddwFs1dbjM-18eYx-_AEItFc8khh63WfW_C_3r1nnWAX5UCzOe2v30tdkC6IjQ8qVRC299Ilec8dQ%24) article from September shed more details: A-listers were ‘quietly singing the drug’s praises’ on the encrypted messaging app Signal, paying $1,500 for a month’s supply, with it now an accepted part of the preparation for red carpet events alongside hair and make-up.
Semaglutide helps lower blood sugar by mimicking a hormone naturally released when you eat a meal, says Ariana Chao, MD, medical director of the Center for ...
Experts also argue that given the difficulty of finding Ozempic, priority should be given to patients with diabetes: “What I worry about, and I hope this is only temporary,” says Kim, is the supply chain. “We also don’t know the side effects or risks in these populations: There may be unknown reactions to the drug.” Obesity is an incurable disease. In that case, he says, drugs like Ozempic and Vigovi may be a great option. “There is no scientific evidence to show that this drug will be effective or beneficial for people who do not meet the criteria for the indications on the FDA-approved label,” says Chao. Ozempic is approved only for type 2 diabetics, and Vegovy only for patients with a BMI greater than 30, or 27 if they have a weight-related co-morbidity, such as high blood pressure. The difference between the two drugs is that Vegovy is administered with a higher dose of semaglutide than Ozempic; Clinical trials have shown greater weight loss but only modest improvements in glycemic control at this high dose, Chao notes. These drugs have led to a shortage of both, which is expected to last for several months, according to the US Food and Drug Administration, raising alarm among diabetics who rely on Ozempic to control their blood sugar levels. There are already several media outlets in Spain that have echoed this use of the drug for diabetes and some centers even advertise it as a solution to being overweight. This may lead to weight loss, but experts note that Ozempic is not approved for this purpose. The second was approved in late 2021 “as a complement to a hypocaloric diet and increased physical activity for weight control, including weight loss and maintenance,” according to the Spanish Medicines Agency. In 2017, the US Food and Drug Administration approved Ozempic for use in individuals with type 2 diabetes. There is a lot of demand for this medicine in America.